A study for a 48 year old woman who takes Tamoxifen Citrate - from FDA reports


3,324 females aged 48 (±5) who take the same drug are studied. This is a personalized study for a 48 year old female patient who has Breast Cancer. The study is created by eHealthMe based on reports from FDA.



On Apr, 16, 2018

3,324 females aged 48 (±5) who take Tamoxifen Citrate are studied.


Number of reports submitted per year:

Tamoxifen Citrate for a 48-year old woman.

Information of the patient in this study:

  • Age: 48
  • Gender: female
  • Conditions: Breast Cancer
  • Drugs taken:
    • Tamoxifen Citrate (tamoxifen citrate)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • Pain in extremity
  • Rashes (redness)
  • Malaise (a feeling of general discomfort or uneasiness)
  • Hot flush (sudden feelings of heat)
  • Nausea (feeling of having an urge to vomit)
  • Headache (pain in head)
  • Dizziness
  • Nausea and vomiting
  • Wound secretion
  • Weight increased
1 - 6 months:
  • Insomnia (sleeplessness)
  • Hot flush (sudden feelings of heat)
  • Constipation
  • Fatigue (feeling of tiredness)
  • High blood pressure
  • Dizziness
  • Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
  • Nasopharyngitis (inflammation of the nasopharynx)
  • Fever
  • Pain in extremity
6 - 12 months:
  • Headache (pain in head)
  • Gums - swollen
  • Hair loss
  • Osteonecrosis of jaw (death of bone of jaw)
  • Aseptic necrosis (the death of bone tissue due to a lack of blood supply)
  • Nail abnormalities (abnormal nail)
  • Cancer pain
  • Abscess jaw (tooth abscess or root abscess)
  • Macular hole (small break in the macula, the central area of the retina)
  • Local swelling (swelling at the site of some application of substance or injury)
1 - 2 years:
  • Depression
  • Fatigue (feeling of tiredness)
  • Aseptic necrosis (the death of bone tissue due to a lack of blood supply)
  • Nausea (feeling of having an urge to vomit)
  • Metastases to bone (cancer spreads to bone)
  • Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  • Muscle spasms (muscle contraction)
  • Impaired healing
  • Feeling abnormal
  • Hypokalemia (low potassium)
2 - 5 years:
  • Joint pain
  • Metastases to bone (cancer spreads to bone)
  • Breathing difficulty
  • Hair loss
  • Muscle aches (muscle pain)
  • Osteopenia (a condition where bone mineral density is lower than normal)
  • Weight increased
  • High blood cholesterol
  • Rashes (redness)
  • Impaired healing
5 - 10 years:
  • Dizziness
  • Bone scan abnormal
  • Osteomyelitis (infection of bone)
  • Fever
  • Bone disorder
  • Bone density decreased
  • Injury
  • Pain
  • Pain in extremity
  • Stress and anxiety
10+ years:
  • Breast cancer recurrent
  • Bone pain
  • High blood cholesterol
  • Muscle aches (muscle pain)
  • Pain in extremity
  • Breathing difficulty
  • Dysstasia (difficulty in standing)
  • Joint pain
not specified:
  • Pain
  • Bone disorder
  • Stress and anxiety
  • Joint pain
  • Osteonecrosis of jaw (death of bone of jaw)
  • Metastases to bone (cancer spreads to bone)
  • Fatigue (feeling of tiredness)
  • Nausea (feeling of having an urge to vomit)
  • Anaemia (lack of blood)
  • Depression

Top conditions involved for these people *:

  • Metastases To Bone (cancer spreads to bone): 203 people, 6.11%
  • Depression : 185 people, 5.57%
  • Breast Cancer Metastatic : 168 people, 5.05%
  • Pain : 108 people, 3.25%
  • Neoplasm Malignant (cancer tumour): 94 people, 2.83%

Top co-used drugs for these people *:

  • Zometa (539 people, 16.22%)
  • Aredia (324 people, 9.75%)
  • Arimidex (288 people, 8.66%)
  • Herceptin (271 people, 8.15%)
  • Taxotere (261 people, 7.85%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?



Related studies:

Related publications that referenced our studies

Can you answer these questions?

More questions for: Tamoxifen citrate, Breast cancer

You may be interested in these posts

More posts for: Tamoxifen citrate, Breast cancer

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.